Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Frontiers in Immunology
|
April 17, 2026
Rational modulation of immune mechanisms synergizes the anti-tumor effects of targeted radiation therapy in pre-clinical models
Tristan Wirtz, Catherine Lee, Sripad Ram, et al.
Molecular Cancer Therapeutics
|
May 15, 2023
Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
Catherine Lee, Ziyue Karen Jiang, Simon Planken, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2019
Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors
Changhua Ji, Marc D Roy, Jonathan Golas, et al.
Mabs
|
February 5, 2014
The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics
Siva Charan Devanaboyina, Sandra M Lynch, Raimund J Ober, et al.
Journal for Immunotherapy of Cancer
|
December 14, 2021
Combinatorial immunotherapy induces tumor-infiltrating CD8<sup>+</sup> T cells with distinct functional, migratory, and stem-like properties
Natalija Van Braeckel-Budimir, Joseph Samuel Dolina, Jie Wei, et al.
Molecular Imaging and Biology
|
June 18, 2021
Preclinical Evaluation of <sup>89</sup>Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell Engaging Therapy
Kevin P Maresca, Jianqing Chen, Divya Mathur, et al.
Molecular Cancer Therapeutics
|
March 21, 2025
18F-FLT PET, a Non-Invasive Pharmacodynamic Biomarker of Tumor Cell Proliferation, Detected Differential Response to Various Cyclin Dependent Kinase (CDK) Inhibitors
Anand Giddabasappa, Ziyue Karen Jiang, Bing Yang, et al.
Nature Communications
|
December 3, 2020
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome
Yeon Hee Park, Samir Lal, Jeong Eon Lee, et al.
Molecular Cancer Therapeutics
|
May 14, 2025
A Novel B7-H4xCD3 Bispecific T Cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune-Checkpoint Therapies
Keith Abayasiriwardana, Lei Wu, Hanane Laklai, et al.
Genome Medicine
|
July 20, 2023
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer
Yeon Hee Park, Seock-Ah Im, Kyunghee Park, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Frontiers in Immunology
|
April 17, 2026
Rational modulation of immune mechanisms synergizes the anti-tumor effects of targeted radiation therapy in pre-clinical models
Tristan Wirtz, Catherine Lee, Sripad Ram, et al.
Molecular Cancer Therapeutics
|
May 15, 2023
Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
Catherine Lee, Ziyue Karen Jiang, Simon Planken, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2019
Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors
Changhua Ji, Marc D Roy, Jonathan Golas, et al.
Mabs
|
February 5, 2014
The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics
Siva Charan Devanaboyina, Sandra M Lynch, Raimund J Ober, et al.
Journal for Immunotherapy of Cancer
|
December 14, 2021
Combinatorial immunotherapy induces tumor-infiltrating CD8<sup>+</sup> T cells with distinct functional, migratory, and stem-like properties
Natalija Van Braeckel-Budimir, Joseph Samuel Dolina, Jie Wei, et al.
Molecular Imaging and Biology
|
June 18, 2021
Preclinical Evaluation of <sup>89</sup>Zr-Df-IAB22M2C PET as an Imaging Biomarker for the Development of the GUCY2C-CD3 Bispecific PF-07062119 as a T Cell Engaging Therapy
Kevin P Maresca, Jianqing Chen, Divya Mathur, et al.
Molecular Cancer Therapeutics
|
March 21, 2025
18F-FLT PET, a Non-Invasive Pharmacodynamic Biomarker of Tumor Cell Proliferation, Detected Differential Response to Various Cyclin Dependent Kinase (CDK) Inhibitors
Anand Giddabasappa, Ziyue Karen Jiang, Bing Yang, et al.
Nature Communications
|
December 3, 2020
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome
Yeon Hee Park, Samir Lal, Jeong Eon Lee, et al.
Molecular Cancer Therapeutics
|
May 14, 2025
A Novel B7-H4xCD3 Bispecific T Cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune-Checkpoint Therapies
Keith Abayasiriwardana, Lei Wu, Hanane Laklai, et al.
Genome Medicine
|
July 20, 2023
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer
Yeon Hee Park, Seock-Ah Im, Kyunghee Park, et al.
Page
of 5